Live Breaking News & Updates on Nasdaq Xfor|Page 7

Stay updated with breaking news from Nasdaq xfor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

X4 Pharmaceuticals (NASDAQ:XFOR) Issues Earnings Results, Misses Expectations By $0.56 EPS

X4 Pharmaceuticals (NASDAQ:XFOR – Get Rating) released its quarterly earnings results on Thursday. The company reported ($1.24) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.68) by ($0.56), MarketWatch Earnings reports. During the same quarter last year, the business earned ($0.91) EPS. NASDAQ XFOR opened at $1.68 on Friday. X4 Pharmaceuticals […] ....

Stifel Nicolaus , Morgan Stanley , Goldman Sachs Group Inc , Zacks Investment Research , Norges Bank , Renaissance Technologies , Pharmaceuticals Company Profile Get Rating , Marshall Wace , Pharmaceuticals Inc , Get Rating , Marketwatch Earnings , Sachs Group , Company Profile , X4 Pharmaceuticals , Nasdaq Xfor ,

X4 Pharmaceuticals Expands Commercial Leadership Expertise

Each brings significant experience in strategic marketing of rare disease therapeutics and commercial operations. ....

United States , Region Flamande , Paula Ragan , Avexis Europe , Rouco Molina , Yale University , Michael Allen Company , Raptor Pharmaceuticals Europe , Exchange Commission , Takeda Pharmaceuticals , Lifesci Communications , Marketing At Vertex Pharmaceuticals , Pharmaceuticals Inc , University Of Leuven , Karolyn Park , Vice President , Chief Executive Officer , Middle East , Latin America , Independent Director , General Manager Europe , Senior Vice President , General Manager , Raptor Pharmaceuticals , Rare Disease Business Unit , Senior Director ,